These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5694390)

  • 21. Breast cancer's forced march?
    Marshall E
    Science; 1992 Oct; 258(5083):732, 734. PubMed ID: 1439774
    [No Abstract]   [Full Text] [Related]  

  • 22. Cost analysis and consequences of the National Cancer Plan.
    Pekar PP
    Fed Proc; 1974 Nov; 33(11):2225-30. PubMed ID: 4430379
    [No Abstract]   [Full Text] [Related]  

  • 23. Research funding. U.S. biomedicine's mother ship braces for lab closings.
    Kaiser J
    Science; 2008 Mar; 319(5868):1324-5. PubMed ID: 18323424
    [No Abstract]   [Full Text] [Related]  

  • 24. FASEB scientists' response to Institute of Medicine report on 'Funding Health Sciences Research'.
    FASEB J; 1990 Dec; 4(15):3271-2. PubMed ID: 2253842
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening for breast cancer. U.S. Preventive Services Task Force, Washington, D.C.
    Am Fam Physician; 1989 Jun; 39(6):89-96. PubMed ID: 2658519
    [No Abstract]   [Full Text] [Related]  

  • 26. Budget cuts and the plight of postdocs.
    Goozner M
    J Natl Cancer Inst; 2013 Feb; 105(3):153-4. PubMed ID: 23334223
    [No Abstract]   [Full Text] [Related]  

  • 27. The time to demand funding.
    Mello CC; Walsh JV
    Science; 2009 Jan; 323(5911):208. PubMed ID: 19131609
    [No Abstract]   [Full Text] [Related]  

  • 28. Report of the Working Group to Review the National Cancer Institute-American Cancer Society Breast Cancer Detection Demonstration Projects.
    J Natl Cancer Inst; 1979 Mar; 62(3):639-709. PubMed ID: 283293
    [No Abstract]   [Full Text] [Related]  

  • 29. Young investigators.
    Freund M
    FASEB J; 1990 Dec; 4(15):3364-5. PubMed ID: 2253853
    [No Abstract]   [Full Text] [Related]  

  • 30. National Institutes of Health/National Cancer Institute consensus development meeting on breast cancer screening: issues and recommendations.
    J Natl Cancer Inst; 1978 Jun; 60(6):1519-21. PubMed ID: 580621
    [No Abstract]   [Full Text] [Related]  

  • 31. Breast cancer prevention trial in limbo.
    Hampton T
    JAMA; 2007 May; 297(18):1968-9. PubMed ID: 17488955
    [No Abstract]   [Full Text] [Related]  

  • 32. Subverting U.S. health.
    Los Angeles Times; 2003 Dec; ():M4. PubMed ID: 14971390
    [No Abstract]   [Full Text] [Related]  

  • 33. Age discrimination in NIH peer review.
    Raub WF
    FASEB J; 1991 Jan; 5(1):116. PubMed ID: 1991579
    [No Abstract]   [Full Text] [Related]  

  • 34. Caught in the middle?
    Magavi SS
    Science; 2008 Sep; 321(5897):1776. PubMed ID: 18818340
    [No Abstract]   [Full Text] [Related]  

  • 35. Grants on the run.
    Jeyaseelan S
    Science; 2009 Jan; 323(5912):337. PubMed ID: 19150826
    [No Abstract]   [Full Text] [Related]  

  • 36. Regarding "ACE Policy Committee letter".
    Ness RB;
    Ann Epidemiol; 2006 Oct; 16(10):796. PubMed ID: 17011479
    [No Abstract]   [Full Text] [Related]  

  • 37. Public and private science.
    Haskins CP
    Am Sci; 1976; 64(5):493-9. PubMed ID: 970725
    [No Abstract]   [Full Text] [Related]  

  • 38. Fostering young investigators.
    Fochtmann LJ
    Science; 1994 Nov; 266(5187):953. PubMed ID: 7973669
    [No Abstract]   [Full Text] [Related]  

  • 39. Percentage of principal investigators (PIs) competing for NIH grants that are funded.
    Flesher JW
    FASEB J; 1990 Dec; 4(15):3364-5. PubMed ID: 2253852
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
    DeWys WD; Greenwald P
    Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.